Valuation: IRADIMED CORPORATION

Market Cap 1.11B 976M 923M 837M 1.57B 106B 1.59B 11.07B 4.27B 54.17B 4.15B 4.06B 174B P/E 2026 *
44.6x
P/E 2027 * 38.4x
Enterprise Value 1.11B 976M 923M 837M 1.57B 106B 1.59B 11.07B 4.27B 54.17B 4.15B 4.06B 174B EV / Sales 2026 *
12x
EV / Sales 2027 * 10.6x
Free-Float
64.82%
Yield 2026 *
-
Yield 2027 * -
1 day-0.19%
1 week+0.15%
Current month+0.12%
1 month+0.12%
3 months-9.50%
6 months-8.92%
Current year-11.10%
1 week 84.57
Extreme 84.57
87.73
1 month 81.4
Extreme 81.405
88.26
Current year 76.95
Extreme 76.95
107.9
1 year 68.68
Extreme 68.68
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 28/05/2020
Director of Finance/CFO 64 20/06/2022
Chief Tech/Sci/R&D Officer - 01/01/2020
Director TitleAgeSince
Chairman 72 16/06/2020
Director/Board Member 70 01/01/2019
Director/Board Member 73 01/01/2014
Date Insider Type Main position Quantity % Market Cap. Importance
9/23/26 A Exercice

Director

1,396 0.0109%
9/3/26 A Sell

Director

-1,419 0.0111%
6/4/26 A Sell

Director

-3,000 0.0235%
Change 5-day change 1-year change 3-year change Capi.($)
-0.20%+0.15%+21.53%+96.32% 1.11B
+0.44%+2.31%+40.34%+37.29% 251B
-0.71%+1.26%+13.16%+4.96% 159B
-1.02%+2.53%-8.68%+38.45% 146B
-0.64%-2.21%-55.31%-17.38% 63.59B
-1.25%+0.06%+11.70%+25.57% 50.77B
-0.09%+5.89%+36.38%+57.84% 49.35B
-1.51%+2.28%-17.32%-20.84% 48.75B
+3.45%+6.32%-3.38%+43.08% 45.1B
+0.35%+5.92%+48.59%+64.68% 43.55B
Average -0.15%+2.59%+8.70%+33.00% 85.81B
Weighted average by Cap. -0.26%+3.06%+12.79%+26.40%

Financials

2026 *2027 *
Net sales 92.07M 81.25M 76.87M 69.72M 131M 8.83B 132M 922M 355M 4.51B 346M 338M 14.52B 104M 91.87M 86.92M 78.83M 148M 9.99B 149M 1.04B 402M 5.1B 391M 382M 16.41B
Net income 24.9M 21.97M 20.79M 18.86M 35.35M 2.39B 35.7M 249M 96.13M 1.22B 93.5M 91.47M 3.93B 29.03M 25.62M 24.24M 21.99M 41.22M 2.79B 41.63M 291M 112M 1.42B 109M 107M 4.58B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
30/09/26 $86.48 +0.02% 29,483
29/09/26 $86.46 -0.23% 204,793
28/09/26 $86.66 +1.05% 150,692
25/09/26 $85.76 +0.66% 146,428
24/09/26 $85.20 -1.33% 123,026
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
86.46USD
Average target price
118.00USD
Spread / Average Target
+36.48%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock